Beam Therapeutics CEO Evans John M. Buys and Sells Shares on January 29-30.
ByAinvest
Monday, Feb 2, 2026 4:10 pm ET1min read
BEAM--
Beam Therapeutics Inc.[BEAM] has announced that Director and CEO, Evans John M., made the following transactions on January 29th, 2026. He purchased 19,336 shares at $0.67 per share and an additional 5,664 shares at the same price. On the same day, he sold 16,333 shares at $29.19 per share and 8,667 shares at $29.74 per share. The following day, January 30th, 2026, he purchased 25,000 shares at $0.67 per share. In contrast, he sold 22,094 shares at $28.27 per share and 2,906 shares at $29 per share.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet